Buscar
Mannatech Inc
MTEXAñadir a la lista de seguimiento
5.080USD
+0.200+4.10%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
9.66MCap. mercado
PérdidaP/E TTM
Más Datos de Mannatech Inc Compañía
Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.
Información de Mannatech Inc
Símbolo de cotizaciónMTEX
Nombre de la empresaMannatech Inc
Fecha de salida a bolsaFeb 16, 1999
Director ejecutivoFredrick (Landen)
Número de empleados189
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección1410 Lakeside Parkway
CiudadFLOWER MOUND
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75028
Teléfono19724717400
Sitio Webhttps://us.mannatech.com/
Símbolo de cotizaciónMTEX
Fecha de salida a bolsaFeb 16, 1999
Director ejecutivoFredrick (Landen)
Ejecutivos de Mannatech Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. J. Stanley Fredrick
Mr. J. Stanley Fredrick
Chairman of the Board
Chairman of the Board
361.76K
--
Mr. Robert A. (Bob) Toth
Mr. Robert A. (Bob) Toth
Vice Chairman of the Board
Vice Chairman of the Board
95.92K
-3.48%
Mr. Kevin Andrew Robbins
Mr. Kevin Andrew Robbins
Director
Director
33.33K
+21.30%
Mr. Larry A. Jobe
Mr. Larry A. Jobe
Independent Board Member
Independent Board Member
--
--
Mr. Tyler Rameson
Mr. Tyler Rameson
Independent Board Member
Independent Board Member
--
--
Ms. Erin K. Barta
Ms. Erin K. Barta
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Mr. Landen Fredrick
Mr. Landen Fredrick
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. John A. (Jack) Seifrick
Mr. John A. (Jack) Seifrick
Independent Board Member
Independent Board Member
--
--
Mr. James Clavijo, CPA
Mr. James Clavijo, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. J. Stanley Fredrick
Mr. J. Stanley Fredrick
Chairman of the Board
Chairman of the Board
361.76K
--
Mr. Robert A. (Bob) Toth
Mr. Robert A. (Bob) Toth
Vice Chairman of the Board
Vice Chairman of the Board
95.92K
-3.48%
Mr. Kevin Andrew Robbins
Mr. Kevin Andrew Robbins
Director
Director
33.33K
+21.30%
Mr. Larry A. Jobe
Mr. Larry A. Jobe
Independent Board Member
Independent Board Member
--
--
Mr. Tyler Rameson
Mr. Tyler Rameson
Independent Board Member
Independent Board Member
--
--
Ms. Erin K. Barta
Ms. Erin K. Barta
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Mannatech Inc?
Los cinco principales accionistas de Mannatech Inc son: Mr. J. Stanley Fredrick
¿Cuántas instituciones poseen acciones de Mannatech Inc (MTEX)?
A fecha de 2026Q1, 39 instituciones poseen acciones de Mannatech Inc, con un valor de mercado combinado de aproximadamente 400.43K, lo que representa el 20.86% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 33379.00.
¿Cuál es la mayor fuente de ganancias de Mannatech Inc?
El 2026Q1, el segmento empresarial Consolidated Product Sales generó la ganancia más alta para Mannatech Inc, ascendiendo a 28.70M y representando el 98.29% de la ganancia total.